Christopher Forsmark is a Gastroenterology physician affiliated with University of Florida. OpenAlex indexes 198 publications with 6,199 citations (h-index 40).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-273-9472Registry record last updated 15 Dec 2016.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcresta Therapeutics, Inc.Program year20251 payment
- Aimmune Therapeutics, Inc.Program year20251 payment
- Mauna Kea Technologies, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
58.9%Solutions for parenteral nutrition58.9%Peg 3350-Electrolyte94%Gavilyte-N6%Part D≥627 patientsMetabolism & gastrointestinal
35.1%Osmotic Laxative32.6%Gavilyte-G78%Gavilyte-C13%Peg-3350 And Electrolytes10%Part D≥285 patientsProton pump inhibitor2.5%Pantoprazole Sodium55%Rabeprazole Sodium45%Part D<11 patientsRespiratory
3.9%Opioid Agonist1.4%Hydrocodone-Acetaminophen100%Part D<11 patientsCystic Fibrosis Transmembrane Conductance Regulator Potentiator1.4%Kalydeco100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Continuation of Type 1 Diabetes in Acute Pancreatitis Consortium – UF Health and AdventHealth Combined Clinical Center
University of Florida
FY2026$480,000U01DK127392 - Continuation of Type 1 Diabetes in Acute Pancreatitis Consortium – UF Health and AdventHealth Combined Clinical Center
University of Florida
FY2025$452,769U01DK127392
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dekosky, MD
University of Florida
Brian Hoh, MD
University of Florida
Frederic Kaye, MD
University of Florida
Kelly Foote, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”